CNS vs GROW

For growth investors, Cohen & Steers, Inc.

(CNS) is the stronger pick with 5. 7% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Cohen & Steers, Inc. (CNS) offers the better valuation at 23. 9x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate Cohen & Steers, Inc. (CNS) a "Sell" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Cohen & Steers, Inc.

(CNS) delivered a total return of +18. 2%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: CNS returned +154. 3% versus GROW's +67. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), U.

S. Global Investors, Inc. (GROW) is the lower-risk stock at 0. 71β versus Cohen & Steers, Inc. 's 0. 98β — meaning CNS is approximately 39% more volatile than GROW relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 25% for Cohen & Steers, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Cohen & Steers, Inc.

(CNS) is pulling ahead at 5. 7% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Cohen & Steers, Inc. grew EPS 14. 2% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cohen & Steers, Inc.

(CNS) is the more profitable company, earning 29. 2% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 29. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNS leads at 33. 4% versus -35. 3% for GROW. At the gross margin level — before operating expenses — CNS leads at 46. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

All stocks in this comparison pay dividends.

U. S. Global Investors, Inc. (GROW) offers the highest yield at 3. 5%, versus 3. 3% for Cohen & Steers, Inc. (CNS).

For long-horizon retirement investors, U.

S. Global Investors, Inc. (GROW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), 3. 5% yield). Both have compounded well over 10 years (GROW: +67. 4%, CNS: +154. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.